PB2069: ELTROMBOPAG WITH IMMUNO SUPPRESSIVE THERAPY IN SEVERE ACQUIRED APLASTIC ANEMIA IN CHILDREN AND ADOLESCENTS: A MONOCENTRIC EXPERIENCE

PB2069: ELTROMBOPAG WITH IMMUNO SUPPRESSIVE THERAPY IN SEVERE ACQUIRED APLASTIC ANEMIA IN CHILDREN AND ADOLESCENTS: A MONOCENTRIC EXPERIENCE

Bibliographic Details
Main Authors:	Nesrine Ben Sayed, Nadia Sassi, Haifa Regaieg, Rim Aidli, Wafa Chenbah, Bouraoui Ouni, Kmira Zahra, Yosra Ben Youssef, Abderrahim Khelif
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975076.08450.f1

Similar Items

PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
by: Wafa Chenbah, et al.
Published: (2023-08-01)

PB2263: TOXICITY PROFILE OF SALVAGE CHEMOTHERAPY REGIMENS IN PATIENTS WITH RELAPSED/ REFRACTORY HODGKIN LYMPHOMA.
by: Kmira Zahra, et al.
Published: (2023-08-01)

PB2556: MEGALOBLASTIC ANEMIA: EPIDEMIOLOGICAL, CLINICAL, AND ETIOLOGICAL PROFILE: ABOUT 200 CASES.
by: Kmira Zahra, et al.
Published: (2023-08-01)

2069
by: Carlton Hornung, et al.
Published: (2017-09-01)

A Case of Acquired Aplastic Anemia after Severe Hepatitis- Probably Induced by the Pfizer/BioNTech Vaccine: A Case Report and Review of Literature
by: Zahra Kmira, et al.
Published: (2023-07-01)

PB2262: PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKINN LYMPHOMA
by: Kmira Zahra, et al.
Published: (2023-08-01)

Acquired hemophilia A following COVID-19 vaccine: a case report
by: Bouselama Emna, et al.
Published: (2023-03-01)

Primary B cell lymphoma of the tongue base: a case report
by: Achour Bechir, et al.
Published: (2016-11-01)

Eltrombopag for the treatment of aplastic anemia: current perspectives
by: Lum SH, et al.
Published: (2016-09-01)

Aplastic Anemia Treated with Eltrombopag during Pregnancy
by: Yuri Suminaga, et al.
Published: (2022-01-01)

Eltrombopag treatment of a dog with idiopathic aplastic pancytopenia
by: Darren Kelly, et al.
Published: (2020-03-01)

Role of eltrombopag in severe aplastic anemia treatment in children
by: Min-Yu Su, et al.
Published: (2021-11-01)

Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
by: Yufei Zhao, et al.
Published: (2023-01-01)

Evaluation of eltrombopag in patients with aplastic anemia in real-world experience
by: Akiko Konishi, et al.
Published: (2019-01-01)

Current evidence and the emerging role of eltrombopag in severe aplastic anemia
by: Beatrice Drexler, et al.
Published: (2021-03-01)

HEMATOLOGIC RECOVERY INDUCED BY ELTROMBOPAG IN PATIENT WITH APLASTIC ANEMIA AFTER TEMOZOLOMIDE
by: ACP Silva, et al.
Published: (2023-10-01)

Osteolytic bone lesions, severe hypercalcemia without circulating blasts: unusual presentation of childhood acute lymphoblastic leukemia
by: Achour Bechir, et al.
Published: (2017-04-01)

Invasive infection caused by Geotrichum capitatum in three patients with acute myeloid leukemia
by: Sana Rouis, et al.
Published: (2020-09-01)

Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia
by: Hong Chang, et al.
Published: (2023-11-01)

Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers
by: Ziqi Wan, et al.
Published: (2023-05-01)

IN VIVO EFFECTS OF ELTROMBOPAG ON THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN APLASTIC ANAEMIA
by: B.Q. Oliveira, et al.
Published: (2020-11-01)

PB2560: LYSOSOMAL STORAGE DISEASES: GUACHER’S DISEASE AND NIEMANPICK ‘S DISEASES: STUDY OF CLINICAL, CYTOLOGICAL AND ENZYMATIC ASPECTS
by: Lina Mohamed, et al.
Published: (2023-08-01)

NATIONAL EXPERIENCE WITH IMMUNOSUPPRESSIVE THERAPY AND ELTROMBOPAG IN CHILDREN WITH APLASTIC ANEMIA- REAL WORLD DATA
by: Katarzyna Pawelec, et al.
Published: (2023-12-01)

The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review
by: Maria Maddalena Marrapodi, et al.
Published: (2023-04-01)

The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
by: Ayşe Işık, et al.
Published: (2013-09-01)

Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia
by: Yihong Guan, et al.
Published: (2022-02-01)

Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States
by: Tremblay G, et al.
Published: (2019-11-01)

Multiple myeloma associated with an Evan's syndrome
by: Achour Bechir, et al.
Published: (2016-11-01)

Eltrombopag with or without Tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial
by: Jiang Ji, et al.
Published: (2023-09-01)

Response of Eltrombopag in immune thrombocytopenia and acquired idiopathic aplastic anemia: A single-center experience
by: Abdul Muqtadir Abbasi, et al.
Published: (2022-01-01)

PB2069: A CASE OF HAIRY CELL LEUKEMIA PRESENTED AS HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
by: C. Almeida, et al.
Published: (2022-06-01)

Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag
by: Ruixin Li, et al.
Published: (2022-05-01)

Outcome of children with severe aplastic anemia treated with eltrombopag added to immunosuppressive therapy - Single centre experience
by: Shweta Pathak, et al.
Published: (2024-01-01)

Follow-Up Of Hemophiles And Management Of Complications
by: Monia Zaier, et al.
Published: (2023-01-01)

Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis
by: Yan Zhang, et al.
Published: (2024-04-01)

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia
by: Margherita Vieri, et al.
Published: (2023-06-01)

S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
by: Ashvind Prabahran, et al.
Published: (2023-08-01)

Paroxysmal nocturnal hemoglobinuria‐phenotype cells predict a good response to eltrombopag in patients with refractory aplastic anemia
by: Ken Ishiyama, et al.
Published: (2020-07-01)

Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center retrospective study in China
by: Zhuxin Zhang, et al.
Published: (2023-09-01)

Correlation of the Plasma Concentration of Eltrombopag With Efficacy in the Treatment of Refractory Aplastic Anemia: A Single-Centre Study in China
by: Wei Zuo, et al.
Published: (2020-11-01)